INNVNasdaqServices-Health ServicesUS GAAP · USD

InnovAge Holding Corp.

InnovAge Holding Corp. operates a PACE-based healthcare delivery platform for frail seniors, with care centered on all-inclusive, capitated services for participants who are often dually eligible for Medicare and Medicaid. The company is headquartered in Denver and runs one reportable segment, PACE, across centers in six U.S. states.

Liikevaihto990milj. USD
+15,9 %v/v
Liikevoitto (EBIT)2,6milj. USD
+108,8 %v/v
EBIT-marginaali0,3%
+3,8 %-yks.v/v
Nettotulos−2,5milj. USD
+91,6 %v/v
Vapaa kassavirta50,4milj. USD
+89,5 %v/v

Tilikausi 2026 · muutos edellisvuodesta

Kehitys 2021–2026

−25002505007501 000milj. USD2021: 638 milj. USD2021: EBIT −12 milj. USD20212022: 699 milj. USD2022: EBIT −4,4 milj. USD20222023: 688 milj. USD2023: EBIT −49 milj. USD20232024: 764 milj. USD2024: EBIT −23 milj. USD20242025: 854 milj. USD2025: EBIT −30 milj. USD20252026: 990 milj. USD2026: EBIT 2,6 milj. USD20269902,6
LiikevaihtoLiikevoitto (EBIT)

Liiketoiminta

Osuus liikevaihdosta
PACE care delivery98 %

Integrated medical, social, and supportive care delivered through PACE centers and home/community services.

Capitation revenue97 %

Monthly per-participant payments from Medicare and Medicaid under state PACE contracts.

Other service revenue1 %

Ancillary revenue mainly from state food grants and rent-related income.

Pharmacy operations1 %

Acquired pharmacy assets and related management services supporting participant medication needs.

Tuotteet

Raportoitu · osuus liikevaihdosta
99,9%FY2026100 %
  • Capitation Revenue99,9 %
  • Other Service Revenue0,1 %

Lähde: 10-K FY2026, yhtiön tuotelinjoittain raportoima liikevaihto (SEC XBRL). Osuudet on laskettu näytetyistä riveistä ja ne summautuvat 100 %:iin.

Asiakkaat

InnovAge serves older adults who are medically complex, often dual-eligible for Medicare and Medicaid, and eligible for nursing-home-level care but able to remain in the community with support. Its economic buyers are primarily government payors through capitated state PACE contracts, while participants and their families are the end users of the care model. The company also works with hospitals, health systems, and other care providers in joint ventures and referral relationships to expand access in target markets.

Dual-eligible seniors

Older adults covered by both Medicare and Medicaid who need coordinated, all-inclusive care.

PACE-eligible frail seniors

Participants meeting nursing-home-level-of-care criteria who use PACE to stay in the community.

Government payors

State Medicaid agencies and Medicare arrangements that fund the capitated model.

Health system partners

Hospitals and local providers that support market entry, referrals, and joint ventures.

Strategia

InnovAge is focused on filling existing center capacity, opening de novo centers, and using tuck-in acquisitions and partnerships to expand its PACE platform. Management also emphasizes tighter regulatory compliance and stronger relationships with Medicare and Medicaid payors, since the model depends on stable capitated reimbursement and successful state contracting.

Grow census at existing centersLyhyt aikaväli

Higher participant density improves operating leverage in a capitated care model.

Build de novo centersKeskipitkä aikaväli

New centers expand the platform into attractive markets and support long-term unit economics.

Acquire and partner in target geographiesKeskipitkä aikaväli

Tuck-ins and joint ventures accelerate market entry and participant growth.

Maintain regulatory complianceLyhyt aikaväli

PACE operations depend on state and federal compliance to preserve contracts and avoid remediation costs.

Maantiede

InnovAge is a U.S.-only operator with centers in California, Colorado, Florida, New Mexico, Pennsylvania, and Virginia. Its footprint is concentrated in state-by-state PACE markets, where local contracting, regulatory compliance, and provider relationships determine growth. The company is also expanding through de novo centers and partnerships in selected target markets, including Florida.

Riskit

InnovAge’s results depend on participant growth, state payor relationships, and strict compliance with PACE regulations, so execution failures can quickly affect revenue and margins. The company also faces healthcare-industry competition, cybersecurity and PHI/PII exposure, and added operational complexity from its new pharmacy business and debt maturities.

Järjestetty vakavuuden mukaan
MatalaKohtalainenKorkeaMatalaKohtalainenKorkeaVaikutus →Todennäköisyys →Growth strategy may not prove viable1Regulatory and contractual compliance failures2Dependence on government payors3Cybersecurity and privacy breaches4Pharmacy business execution risk5Refinancing and liquidity risk6
Vaikutus on riskin vakavuus ja todennäköisyys sen toteutumisen todennäköisyys lähivuosina, molemmat arvioitu yhtiön raporttien perusteella. Numerot vastaavat listaa.
  1. Growth strategy may not prove viableVaikutus: KorkeaTodennäköisyys: Korkea

    Expansion depends on new geographies, participant recruitment, and successful center execution.

    KohdistuuEnrollmentNew center launchesAcquisitionsPartnerships
  2. Regulatory and contractual compliance failuresVaikutus: KorkeaTodennäköisyys: Korkea

    PACE is heavily regulated and state contracts must be maintained in good standing.

    KohdistuuAuditsRemediation plansState contract renewals
  3. Dependence on government payorsVaikutus: KorkeaTodennäköisyys: Korkea

    The model relies on Medicare and Medicaid capitation rates and state contracting.

    Kohdistuu: Revenue concentration in public payors

  4. Cybersecurity and privacy breachesVaikutus: KeskitasoTodennäköisyys: Kohtalainen

    The company and vendors handle sensitive PHI/PII and face HIPAA-related obligations.

    Kohdistuu: Third-party service providers and internal systems

  5. Pharmacy business execution riskVaikutus: KeskitasoTodennäköisyys: Kohtalainen

    InnovAge has limited prior experience operating pharmacy services and may not realize expected synergies.

    Kohdistuu: Acquired pharmacy assets and management services agreement

  6. Refinancing and liquidity riskVaikutus: KeskitasoTodennäköisyys: Kohtalainen

    Debt maturities can pressure cash flow and require refinancing on acceptable terms.

    Kohdistuu: Term loan maturity and revolving facility usage

Kirjanpito

Harkinnanvaraiset erät
Capitation revenue recognition

Revenue is based on PMPM payments under Medicare and Medicaid PACE contracts.

Vaikutus: Affects timing and stability of reported revenue

Participant and provider cost estimates

Medical, housing, outpatient, and pharmacy costs are major expense drivers.

Vaikutus: Affects margins and quarterly earnings volatility

Acquisition accounting for pharmacy assets

The company recently acquired pharmacy assets and must value related assets and liabilities.

Vaikutus: Can affect amortization, goodwill, and future impairment risk

Lease and center expansion accounting

PACE centers require facility build-outs and lease commitments.

Vaikutus: Affects right-of-use assets, depreciation, and occupancy costs

Julkisesti listattuja yhtiöitä, joilla on samankaltainen liiketoiminta.

Päivitetty: 24.9.2026

InnovAge Holding Corp. (INNV) liikevaihto, tulos ja tunnusluvut 2026 – Clarifo